Aarsleff’s acquisition of shares in Trym Anlegg AS has been approved

5.7.2022 11:04:47 CEST | Per Aarsleff Holding A/S |
Selskabsmeddelelse
Per Aarsleff Holding A/S meddelte den 24. juni 2022, at vi havde indgået aftale om at overtage 66,6 % af aktierne i Trym Anlegg AS.
Overtagelsen var betinget af de norske konkurrencemyndigheders godkendelse. Denne godkendelse har vi modtaget i dag. 
Overtagelsen gennemføres formelt den 12. juli 2022. 
For yderligere information se venligst selskabsmeddelelsen ”Aarsleff indgår betinget aftale om overtagelse af aktier i norsk banespecialist” udsendt den 24. juni 2022.
Kontakter

Jesper Kristian Jacobsen, Administrerende direktør / CEO, +45 8744 2222

Om Per Aarsleff Holding A/S
Aarsleff-koncernen opererer på internationalt niveau inden for anlæg og byggeri med udgangspunkt i en førende position i Danmark. Koncernen består af en portefølje af selvstændige konkurrencedygtige selskaber med hver deres særlige kompetencer.
Vedhæftninger

Trym Anlegg_godkendt_DK.pdf

5.7.2022 11:04:47 CEST | Per Aarsleff Holding A/S |
Company Announcement
On 24 June 2022, Per Aarsleff Holding A/S announced that the company had entered into an agreement on acquisition of 66.6% of the shares in Trym Anlegg AS. 
The acquisition was subject to the approval of the Norwegian competition authorities. Today we have received this approval from the Norwegian competition authorities. 
The acquisition will formally take place on 12 July 2022. 
For further information, we refer to the company announcement of 24 June 2022 “Aarsleff enters into conditional agreement on acquisition of shares in Norwegian railway specialist”.
Contacts

Jesper Kristian Jacobsen, Administrerende direktør / CEO, +45 8744 2222

About Per Aarsleff Holding A/S
The Aarsleff Group is a building construction and civil engineering group with an international scope and a market leading position in Denmark. The Group comprises a portfolio of independent, competitive companies each with their own specialist expertise. 
Attachments

Trym Anlegg_godkendt_UK.pdf

Leave a Reply